Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and ...

Viking Therapeutics remains a compelling obesity drugs contender, despite being in the pre-commercial phase. VKTX's ...

Viking just dropped a nonstick skillet that won’t flake or scratch like so many other nonstick pans. Grab this tough-as-nails titanium skillet while it’s on sale at Amazon.

Viking's Chairman and CEO Torstein Hagen shared a video in which he reflected on the milestones his company achieved in 2025. “The past 12 months have been busy for us at Viking. We continued to ...

Luxury cruise operator Viking (NYSE:VIK) in Q3 CY2025, with sales up 19.1% year on year to $2 billion. Its GAAP profit of ...

VKTX remains a Buy for its cheap FY2030 EV/Sales valuations of 2.28x, the strong clinical trial results exceeding legacy ...

Set aside any bucket list sailings you might have in mind. As an investor, which stock is the best choice right now. Carnival ...

Pass the mead, because Viking Therapeutics has plenty to celebrate after its dual agonist of GLP-1 and GIP was linked to weight loss of up to 14.7% after 13 weeks of treatment, sending the biotech's ...

A ship’s traveler rating is provided under license by Cruiseline.com, which manages one of the largest databases of cruise reviews and ratings by travelers. A total of 73 guests have reviewed Viking ...

Viking Global Investors, the $27 billion investment giant led by Ole Andreas Halvorsen, is making waves with bold bets in the financial sector. Topping Viking's portfolio with a 5.6% allocation, U.S.